Ob-gyn group lists procedures that may not be needed

March 3, 2013 in Obstetrics & gynaecology

Ob-gyn group lists procedures that may not be needed

As part of the 'Choosing Wisely' campaign, ACOG asks docs, patients to question certain practices.

(HealthDay)—Five tests and procedures that obstetricians/gynecologists and their patients should question the need for are outlined in a list released by the American College of Obstetricians and Gynecologists (ACOG) as part of the Choosing Wisely campaign.

The American Board of Internal Medicine Foundation-led campaign involves about 35 medical specialty groups and is intended to encourage patients and doctors to discuss appropriate care while avoiding unnecessary tests and treatments. ACOG is one of 17 medical societies that recently released advice lists.

"We carefully selected the five procedures and tests in ob-gyn based on their potential to improve quality health care and avoid potential harm. As ob-gyns, our goal is to provide women the very best evidence-based medical care," Dr. Hal Lawrence III, ACOG executive vice president, said in a college news release.

Here are the ACOG recommendations:

  • Elective, non-medically indicated inductions of labor or should not be scheduled before 39 weeks' gestation. Delivery prior to 39 weeks has been shown to be associated with an increased risk of learning disabilities and a potential increase in illness and death.
  • Elective, non-medically indicated inductions of labor between 39 weeks' and 41 weeks' gestation should not be scheduled unless the cervix is deemed favorable.
  • Routine annual Pap tests are not needed in women aged 30 to 65. In average-risk women, an annual screening offers no advantages over screening every three years.
  • Treatment is not needed in average-risk women who have "mild dysplasia," which is associated with the (HPV), for a period of less than two years.
  • For average-risk women with no symptoms, there is no need to screen for . In these , the potential harms of screening outweigh the potential benefits.

More information: Here's where you can learn more about the Choosing Wisely campaign.

Health News Copyright © 2013 HealthDay. All rights reserved.

not rated yet  

Rank not rated yet
Related Stories
Relevant PhysicsForums posts

More news stories

Bulletin provides guidelines for second-trimester abortion

(HealthDay)—New evidence-based guidelines provide guidance on medical and surgical methods for second-trimester abortion and management of associated complications, according to a practice bulletin published ...

Obstetrics & gynaecology created May 24, 2013 | popularity not rated yet | comments 1

ACOG: Hormone therapy not recommended to prevent CHD

(HealthDay)—Menopausal hormone therapy should not be used for prevention of coronary heart disease, according to a Committee Opinion from the American College of Obstetricians and Gynecologists (ACOG) published ...

Obstetrics & gynaecology created May 24, 2013 | popularity not rated yet | comments 0

Iodine deficiency during pregnancy may adversely affect children's mental development

A study of around 1,000 UK mothers and their children, published in The Lancet, has revealed that iodine deficiency in pregnancy may have an adverse effect on children's mental development. The research raises concerns that t ...

Obstetrics & gynaecology created May 21, 2013 | popularity not rated yet | comments 0

72 percent of pregnant women experience constipation and other bowel problems

Nearly three out of four pregnant women experience constipation, diarrhea or other bowel disorders during their pregnancies, a Loyola University Medical Center study has found.

Obstetrics & gynaecology created May 20, 2013 | popularity not rated yet | comments 0

Women's reproductive ability may be related to immune system status

New research indicates that women's reproductive function may be tied to their immune status. Previous studies have found this association in human males, but not females.

Obstetrics & gynaecology created May 17, 2013 | popularity not rated yet | comments 0 | with audio podcast


First drug to improve heart failure mortality in over a decade

Coenzyme Q10 decreases all cause mortality by half, according to the results of a multicentre randomised double blind trial presented today at Heart Failure 2013 congress. It is the first drug to improve heart failure mortality ...

Seniors more likely to crash when driving with pet, study finds

(HealthDay)—Animals make great companions for senior citizens, but elderly people who always drive with a pet in the car are far more likely to crash than those who never drive with a pet, researchers have ...

Heart failure accelerates male 'menopause'

Heart failure accelerates the aging process and brings on early andropausal syndrome (AS), according to research presented today at the Heart Failure Congress 2013. AS, also referred to as male 'menopause', was four times ...

Death highest in heart failure patients admitted in January, on Friday, and overnight

Mortality and length of stay are highest in heart failure patients admitted in January, on Friday, and overnight, according to research presented today at the Heart Failure Congress 2013. The analysis of nearly 1 million ...

Feds fight morning-after pill age ruling in NY

(AP)—Department of Justice lawyers have again asked a federal appeals court in New York to delay lifting age restrictions and prescription requirements on an emergency contraceptive popularly known as the morning-after ...

New immune system discovered

(Medical Xpress)—A research team, led by Jeremy Barr, a biology post-doctoral fellow, unveils a new immune system that protects humans and animals from infection.